Published in Women's Health Weekly, October 20th, 1997
The new Digene HPV Test is based on the company's Hybrid Capture II technology, which permits simultaneous testing of multiple samples from a single 96-well microtiter plate and is designed to be more efficient, less expensive, and easier to use than Hybrid Capture I, the company's first generation detection technology. Digene's Hybrid Capture I HPV test is the only FDA-approved test for the detection of human papillomavirus (HPV), the cause of essentially all...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly